SR419

DRUG4 trials

Sponsors

Shanghai SIMR Biotechnology Co., Ltd., SIMR (Australia) Biotech Pty Ltd.

Conditions

HealthyHealthy VolunteersPeripheral Neuropathic PainPostherpetic Neuralgia

Phase 1

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

CompletedNCT04021563

Shanghai SIMR Biotechnology Co., Ltd.Healthy Volunteers

Start: 2019-07-26End: 2019-12-10Updated: 2024-11-29

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

CompletedNCT04494815

Shanghai SIMR Biotechnology Co., Ltd.Peripheral Neuropathic Pain

Start: 2020-09-18End: 2022-07-31Updated: 2025-08-13

A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects

CompletedNCT04705077

SIMR (Australia) Biotech Pty Ltd.Healthy

Start: 2021-02-02End: 2021-03-12Updated: 2021-03-25

Phase 2

To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN)

CompletedNCT05357677

Shanghai SIMR Biotechnology Co., Ltd.Postherpetic Neuralgia

Start: 2022-05-13End: 2023-01-18Updated: 2024-01-05